Table 2 Patients’ characteristics
From: Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
Age (years, mean ± standard deviation) | 67.1 ± 10.4 |
Female gender | 83.3% |
Educational level | |
Primary | 8.4% |
Some high school | 35.9% |
High school graduate | 30.3% |
College or university | 25.5% |
Size of household | |
One person | 29.9% |
Two people | 55.1% |
Three or more people | 15.0% |
Monthly household income | |
Up to €999 | 5.5% |
€1,000 to 1,499 | 33.1% |
€1,500 to 1,999 | 19.1% |
€2,000 to 2,499 | 17.8% |
€2,500 to 2,999 | 11.9% |
€3,000+ | 12.7% |
Diagnosis of osteoporosis | 89.8% |
Years since osteoporosis (mean ± standard deviation) | 8.9 ± 0.3 |
With prior fracture(s) | 52.5% |
In the last year | 22.8% |
Patients on osteoporotic treatment | 69.8% |
Administration mode of current treatment | |
Oral | 72.2% |
Subcutaneous injection | 15.4% |
Intravenous injection | 12.4% |
Number of co-treatments | |
Zero or one | 19.3% |
Two or three | 40.6% |
Four or more | 40.2% |
10-year probability of a major osteoporotic fracture (FRAX) (mean ± standard deviation) | 14.3 ± 7.5% |
10-year probability of a hip fracture (FRAX) (mean ± standard deviation) | 6.1 ± 5.3% |